HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.

AbstractBACKGROUND AND PURPOSE:
Activation of poly(ADP-ribose) polymerase (PARP) is deleterious during cerebral ischemia. We assessed the influence of PARP activation induced by cerebral ischemia on the synthesis of proinflammatory mediators including the cytokines, tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) and the adhesion molecules, E-selectin and intercellular adhesion molecule-1 (ICAM-1).
EXPERIMENTAL APPROACH:
Ischemia was induced by intravascular occlusion of the left middle cerebral artery for 1 h in male Swiss mice anaesthetized with ketamine and xylazine. The PARP inhibitor PJ34 (1.25-25 mg kg(-1)) was administered intraperitoneally 15 min before and 4 hours after, the onset of ischemia. Animals were killed 6 h or 24 h after ischemia and cerebral tissue removed for analysis.
KEY RESULTS:
Ischemia increased TNF-alpha protein in cerebral tissue at 6 and 24 h after ischemia. All doses of PJ34 blocked the increase in TNF-alpha at 6 h and 25 mg kg(-1) PJ34 had a sustained effect for up to 24 h. Quantitative real time polymerase chain reaction showed that PJ34 (25 mg kg(-1)) reduced the increase in TNF-alpha mRNA by 70% at 6 h. PJ34 also prevented the increase in mRNAs encoding IL-6 (-41%), E-selectin (-81%) and ICAM-1 (-54%). PJ34 (25 mg kg(-1)) reduced the infarct volume (-26%) and improved neurological deficit, 24 h after ischemia.
CONCLUSIONS AND IMPLICATIONS:
PJ34 inhibited the increase in the mRNAs of four inflammatory mediators, caused by cerebral ischemia. The contribution of this effect of PJ34 to neuroprotection remains to be clarified.
AuthorsM Haddad, H Rhinn, C Bloquel, B Coqueran, C Szabó, M Plotkine, D Scherman, I Margaill
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 149 Issue 1 Pg. 23-30 (Sep 2006) ISSN: 0007-1188 [Print] England
PMID16865091 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents
  • Cell Adhesion Molecules
  • Cytokines
  • E-Selectin
  • Enzyme Inhibitors
  • Interleukin-6
  • N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride
  • Phenanthrenes
  • Poly(ADP-ribose) Polymerase Inhibitors
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
Topics
  • Animals
  • Anti-Inflammatory Agents
  • Brain (pathology)
  • Cell Adhesion Molecules (biosynthesis)
  • Cerebral Infarction (pathology)
  • Cytokines (biosynthesis)
  • Dose-Response Relationship, Drug
  • E-Selectin (biosynthesis)
  • Enzyme Inhibitors (pharmacology)
  • Intercellular Adhesion Molecule-1 (biosynthesis)
  • Interleukin-6 (biosynthesis)
  • Ischemic Attack, Transient (pathology)
  • Male
  • Mice
  • Nervous System Diseases (chemically induced, physiopathology)
  • Phenanthrenes (pharmacology)
  • Poly(ADP-ribose) Polymerase Inhibitors
  • RNA, Messenger (biosynthesis)
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: